Alaunos Therapeutics (TCRT) EBITDA Margin (2011 - 2025)
Alaunos Therapeutics (TCRT) reported EBITDA Margin of -30000.00% for Q4 2025, down 11100.00 percentage points from -18900.00% a year earlier.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) EBITDA Margin (2011 - 2025) Analysis & Trends
For FY2025, Alaunos Therapeutics posted EBITDA Margin of -84360.00%, down 36260.00 percentage points from FY2024.
- EBITDA Margin has a four-year change of -65622.75 percentage points (FY2021 to FY2025).
- By year, EBITDA Margin came in at -48100.00% in FY2024 (+590940.00 pp), -639040.00% in FY2023 (-637934.42 pp), -1105.58% in FY2022 (+17631.67 pp) and -18737.25% in FY2021.
- Five-year quarterly EBITDA Margin spans a low of -770800.00% in Q4 2023 and a high of -260.15% in Q3 2022.
- Year over year, EBITDA Margin gained in three of the last four quarters, with an average year-over-year change of +253287.50 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Alaunos Therapeutics | 4.38 Mn | 576,050.88 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -30,000.00% |
| Mar 31, 2025 | -54,600.00% |
| Dec 31, 2024 | -18,900.00% |
| Jun 30, 2024 | -29,125.00% |
| Mar 31, 2024 | -174,000.00% |
| Dec 31, 2023 | -770,800.00% |
| Jun 30, 2023 | -160,400.00% |
| Dec 31, 2022 | -67,627.27% |
| Sep 30, 2022 | -252.28% |
| Dec 31, 2021 | -505,400.00% |
| Sep 30, 2021 | -5,395.73% |
| Mar 31, 2018 | -11,013.01% |
| Sep 30, 2017 | -812.64% |
| Jun 30, 2017 | -809.39% |
| Mar 31, 2017 | -869.51% |
| Dec 31, 2016 | -691.80% |
| Sep 30, 2016 | -678.47% |
| Jun 30, 2016 | -7,728.87% |
| Mar 31, 2016 | -607.82% |
| Dec 31, 2015 | -490.88% |
API Access
Alaunos Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();